Headache and Other Symptoms in Chiari Malformation Type I Are Associated with Cerebrospinal Fluid Flow Improvement After Decompression: A Two-Institutional Study.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
07 2022
Historique:
received: 03 02 2022
revised: 23 03 2022
accepted: 24 03 2022
pubmed: 2 4 2022
medline: 24 6 2022
entrez: 1 4 2022
Statut: ppublish

Résumé

Chiari malformation type I (CMI) is a common neurologic condition and surgery is the standard treatment. We aim to establish the cerebrospinal fluid (CSF) flow change as a potential objective indicator of surgical efficacy to improve symptoms. We performed a retrospective 2-center analysis of surgically treated patients with CMI. Qualitative CSF flow studies obtained preoperatively and postoperatively were analyzed by the neuroradiologist, seeking improvement in CSF flow. Symptom status, including headache and neck pain, were recorded. Forty-nine patients were identified between 2010 and 2017. The average age was 36 years, with 47 females. After decompression, CSF flow was improved in 41 patients (group A) and unchanged in 8 (group B). Group A and B had a mean age of 34 and 42 years (P < 0.05) and an average tonsillar herniation of 8.3 and 8.5 mm (P = 0.40), respectively. Group A had improved clinical outcomes, compared with group B (P = 0.024), more specifically, in headache (50% vs. 37%), neck pain (66% vs. 33%), dizziness (78% vs. 50%), vision symptoms (84% vs. 80%), and weakness (100% vs. 66%), respectively. Group B had the only patient who did worse on clinical follow-up. Patients with CMI often present with a constellation of symptoms. We showed a significant association between improved CSF flow after decompression and symptom alleviation. Further, our study suggests that the presence of improved CSF flow postoperatively could represent an objective indicator for improved patient outcomes.

Identifiants

pubmed: 35364297
pii: S1878-8750(22)00402-8
doi: 10.1016/j.wneu.2022.03.108
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e253-e262

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Luke Mugge (L)

Department of Neurosciences, Inova Neuroscience and Spine Institute, Falls Church, Virginia, USA.

Andrew Caras (A)

Department of Neurosurgery, Virginia Commonwealth University, Richmond, Virginia, USA.

Nicholas Henkel (N)

Department of Neurosurgery, The University of Toledo Medical Center, Toledo, Ohio, USA.

Camila Dassi (C)

Department of Neurosurgery, The Ohio State University Medical Center, Columbus, Ohio, USA.

Jason Schroeder (J)

Department of Neurosurgery, The University of Toledo Medical Center, Toledo, Ohio, USA.

Daniel M Prevedello (DM)

Department of Neurosurgery, The Ohio State University Medical Center, Columbus, Ohio, USA. Electronic address: Daniel.Prevedello@osumc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH